Synthesis, Characterization, In Vitro Anticancer Evaluation, ADMET Properties, and Molecular Docking of Novel 5‐Sulfanyl Substituted (Thiazol‐4‐yl)‐Phosphonium Salts
ChemMedChem · 2024
DOI: 10.1002/cmdc.202400205 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2024. Verfasst von Ivan Semenyuta und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of chemistry of natural compounds, V. P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry, NAS of Ukraine, Academician Kukhar s…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Molecular Docking Simulation, Drug Screening Assays, Antitumor, Cell Proliferation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Cancer Institute, Bethesda, MD, USA.
Abstract (Originalsprache)
Seven TPP+ new 5‐sulfanyl substituted (thiazol‐4‐yl) phosphonium salts functionalized with different substituents were designed, synthesized, and studied against the NCI‐60 human cancer cell lines. Compounds 1–4 show the total average parameters GI 50 =0.7–2.7 μM, TGI=7.0–14.6 μM, and LC 50 =25.2–41.8 μM, and compounds 5–7 show GI 50 =0.3–0.5 μM, TGI=1.3–3.1 μM, and LC 50 =3.6–4.0 μM. The most active compound 7 demonstrated the best anticancer results against leukemia (K‐562, GI 50 =0.141 μM; RPMI‐8226, GI 50 =0.143 μM), ovarian cancer (NCI/ADR‐RES, GI 50 =0.142 μM), breast cancer (HS578T, GI 50 =0.175 μM; MDA‐MB‐468, GI 50 =0.101 μM), melanoma (SK‐MEL‐5, GI 50 =0.155 μM), and colon cancer (COLO 205, GI 50 =0.163 μM). All compounds showed low cytotoxicity against the leukemia subpanel (LC 50 >100 μM). The SAR analysis reveals the critical role of the substitutes at the thiazole C2 and C5 positions. Adding the phenyl, p‐tolyl, or 4‐chlorophenyl group to the C2 position in compounds 5 – 7 increases anticancer effectiveness. According to the NCI COMPARE analysis, compounds 2 – 3 showed a very high (r=0.92, 0.81) correlation with morpholino‐doxorubicin. Molecular docking‐analyzing the antitumor mechanism of compounds 1 – 4 action demonstrated that the DNA chain is a probable biotarget. The ADMET analysis acknowledges the favorable prognosis using compounds as potential anticancer agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of chemistry of natural compounds, V. P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry, NAS of Ukraine, Academician Kukhar st. 1, 02094, Kyiv, Ukraine.
- Department of chemistry of bioactive nitrogen-containing heterocyclic bases, V. P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry, NAS of Ukraine, Academician Kukhar st. 1, 02094, Kyiv, Ukraine.
ORCID-Profile: Ivan Semenyuta, Oleksandr Golovchenko, Oksana Bahrieieva, Roman Vydzhak, Victor Zhirnov, Volodymyr Brovarets
Förderung
- National Cancer Institute, Bethesda, MD, USA
Zitieren
APA
Semenyuta, I., Golovchenko, O., Bahrieieva, O., Vydzhak, R., Zhirnov, V., & Brovarets, V. (2024). Synthesis, Characterization, In Vitro Anticancer Evaluation, ADMET Properties, and Molecular Docking of Novel 5‐Sulfanyl Substituted (Thiazol‐4‐yl)‐Phosphonium Salts. ChemMedChem. https://doi.org/10.1002/cmdc.202400205
Vancouver
Semenyuta I, Golovchenko O, Bahrieieva O, Vydzhak R, Zhirnov V, Brovarets V. Synthesis, Characterization, In Vitro Anticancer Evaluation, ADMET Properties, and Molecular Docking of Novel 5‐Sulfanyl Substituted (Thiazol‐4‐yl)‐Phosphonium Salts. ChemMedChem. 2024. doi:10.1002/cmdc.202400205
BibTeX
@article{Semenyuta2024,
author = {Semenyuta, Ivan and Golovchenko, Oleksandr and Bahrieieva, Oksana and Vydzhak, Roman and Zhirnov, Victor and Brovarets, Volodymyr},
title = {Synthesis, Characterization, In Vitro Anticancer Evaluation, ADMET Properties, and Molecular Docking of Novel 5‐Sulfanyl Substituted (Thiazol‐4‐yl)‐Phosphonium Salts},
journal = {ChemMedChem},
year = {2024},
doi = {10.1002/cmdc.202400205}
}
EUVIMED